Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-043720·Cidara Therapeutics, Inc.
Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 171757206
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vivo Opportunity Fund Holdings, L.P.
Shares: 612,276.00 · Class: 4.7%
- Vivo Opportunity, LLC
Shares: 612,276.00 · Class: 4.7%
- Vivo Opportunity Cayman Fund, L.P.
Shares: 72,000.00 · Class: 0.6%
- Vivo Opportunity Cayman, LLC
Shares: 72,000.00 · Class: 0.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-043720
- Form type
- SCHEDULE 13G/A
- Filer
- Cidara Therapeutics, Inc.
- CIK
- CIK 1610618
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership